Abstract
Nanomaterials have attracted much interest in the medical field and related applications as their distinct properties in the nanorange enable new and improved diagnosis and therapies. Owing to these properties and their potential interactions with the human body and the environment, the impact of nanomaterials on humans and their potential toxicity have been regarded a very significant issue. Consequently, nanomaterials are the subject of a wide range of cutting-edge research efforts in the medical and related fields to thoroughly probe their potential beneficial utilizations and their more negative effects. We posit that the lack of standardization in the field is a serious shortcoming as it has led to the establishment of methods and results that do not ensure sufficient consistency and thus in our view can possibly result in research outputs that are not as robust as they should be. The main aim of this article is to present how NanoDiaRA, a large FP7 European multidisciplinary project that seeks to investigate and develop nanotechnology-based diagnostic systems, has developed and implemented robust, standardized methods to support research practices involving the engineering and manipulation of nanomaterials. First, to contextualize this research, an overview of the measures defined by different regulatory bodies concerning nanosafety is presented. Although these authorities have been very active in the past several years, many questions remain unanswered in our view. Second, a number of national and international projects that attempted to ensure more reliable exchanges of methods and results are discussed. However, the frequent lack of publication of procedures and protocols in research can often be a hindrance for sharing those good practices. Subsequently, the efforts made through NanoDiaRA to introduce standardized methods and techniques to support the development and utilization of nanomaterials are discussed in depth. A series of semi-structured interviews were conducted with the partners of this project, and the interviews were analyzed thematically to highlight the determined efforts of the researchers to standardize their methods. Finally, some recommendations are made toward the setting up of well-defined methods to support the high-quality work of collaborative nanoparticle-based research and development projects and to enhance standardization processes.
Similar content being viewed by others
Notes
Partners of project DaNa are DECHEMA e.V. Frankfurt/Main, Fraunhofer Institute for Ceramic Technologies and Systems Dresden, Helmholtz Center for Environmental Research Leipzig, Karlsruhe Institute of Technology, Independent Institute for Environmental Issues Berlin (Germany), and Empa St. Gallen (Switzerland).
References
European Commission (2011) Commission recommendation of 18 October 2011 on the definition of nanomaterial. Off J Eur Union 275:38–40
Koodali RT, Klabunde KJ (2012) Nanotechnology: fundamental principles and applications. In: Kent JA (ed) Handbook of industrial chemistry and biotechnology, vol 1. Springer, New York
Boddoes CM, Case CP, Briscoe WH (2015) Understanding nanoparticle cellular entry: a physicochemical perspective. Adv Colloid Interf Sci 218:48–68
Georgieva JV, Hoekstra D, Zuhorn IS (2014) Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood–brain barrier. Pharmaceutics 6(4):557–583
Wang H, Thorling CA, Liang X, Bridle KR, Grice JE, Zhu Y, Crawford DHG, Xu ZP, Liu X, Roberts MS (2015) Diagnostic imaging and therapeutic application of nanoparticles targeting the liver. J Mater Chem B 3:939–958
Xu C, Sun S (2013) New forms of superparamagnetic nanoparticles for biomedical application. Adv Drug Deliv Rev 65(5):732–743
Jin R, Lin B, Li D, Ai H (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27
EMEA (2006) Reflection paper on nanotechnology-based medicinal products for human use. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2010/01/WC500069728.pdf. Accessed 13 Dec 2015
EFSA (2009) The potential risks arising from nanoscience and nanotechnologies on food and feed safety. http://www.efsa.europa.eu/de/efsajournal/pub/958. Accessed 13 Dec 2015
FDA (2007) Nanotechnology task force report. Commisioner of food and drugs. http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/UCM2006659.htm.
Tolaymat T, El Badawy A, Sequeira R, Genaidy A (2015) An integrated science based-methodology to assess potential risks and implications of engineered nanomaterials. J Hazard Mater 298:270–281
Reinsborough MT, Sullivan G (2011) The regulation of nano-particles under the European biocidal products directive: challenges for effective civil society participation. Eur J Law Technol 2 (3)
Gaspar R (2007) Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals. Nanomedicine 2(2):143–147. doi:10.2217/17435889.2.2.143
Toy R, Peiris PM, Gaghada KB, Karathanasis E (2014) Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomed Nanotechnol Biol Med 9(1):121–134
Science and technology policy: nanotechnology (2012) OECD. http://www.oecd.org/sti/nano/. Accessed 29 Nov 2014
EC (2011) High-level expert group on key enabling technologies - final report. European Commission. http://ec.europa.eu/enterprise/sectors/ict/files/kets/hlg_report_final_en.pdf
OECD (2009) Preliminary review of OECD test guidelines for their applicability to manufactured nanomaterials (series on the safety of manufactured nanomaterials 15). OECD, Paris
Testing of chemicals (2013) OECD. http://www.oecd.org/chemicalsafety/testing/. Accessed 29 Nov 2014
ISO/TC 229 Nanotechnologies (2005) International Organization for Standardization (ISO). http://www.iso.org/iso/iso_technical_committee?commid=381983. Accessed Nov 2014
International Organization for Standardization (ISO) (2008) Nanotechnologies - terminology and definitions for nanoobjects - nanoparticle, nanofibre and nanoplate, ISO/TS 27687:2008. ISO, Geneva
ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. S2(R1), step 4 (harmonised tripartite guideline). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Geneva
European Chemicals Agency (ECHA) (2013) Guidance on the compilation of safety data sheets, version 2.0, ECHA-13-G-11-EN. ECHA, Helsinki
Bundesamt für Gesundheit (BAG) (2013) Das Sicherheitsdatenblatt in der Schweiz basierend auf der 4. BAG (Federal Office of Public Health), Bern, Revision der ChemV gültig ab 1.12.2012
State Secretariat for Economic Affairs (SECO) (2012) Safety data sheet (SDS): guidelines for synthetic nanomaterials. Federal Department of Economic Affairs (DEA) – SECO, Bern
Bleeker EAJ, Cassee FR, Geertsma RE, De Jong WH, Heugens EHW, Koers-Jacquemijns M, van De Meent D, Oomen AG, Popma J, Rietveld AG, Wijnhoven SWP (2012) Interpretation and implications of the European commission recommendation on the definition of nanomaterial (RIVM Letter Report 601358001/2012). RIVM, Bilthoven
Rauscher H (2012) The European Commission’s recommendation on the definition of nanomaterial makes an impact. Nanotoxicology 7(7):1195–1197
Fulda C, Weber-Bruls D, Werth J (2014) Nano is nano is nano or: nanotechnology—a European legal perspective. Nanotechnol Rev 3(4):401–409
Hofmann-Amtenbrink M, Hofmann H, Hool A, Roubert F (2014) Nanotechnology in medicine: European research and its implications. Swiss Med Wkly 144:w14044. doi:10.4414/smw.2014.14044
CORDIS (2015) NANODEFINE periodic report summary 1. European Commission. http://cordis.europa.eu/result/rcn/163274_en.html. Accessed 26 May 2015
Kurath M, Nentwich M, Fleischer T, Eisenberger I (2014) Cultures and strategies in the regulation of nanotechnology in Germany, Austria, Switzerland and the European Union. NanoEthics 8(2):121–140
Bergkamp L, Michaux G, Herbatschek N (2014) Nanotechnology regulation in Europe: from REACH and nano-registries to cosmetics, biocides, and medical devices. Nanotechnol Law Bus 11(1):93
JRC-IHCP (2009) REACH implementation project on nanomaterials (RIP-oN) (2009) substance identification of nanomaterials, vol 1. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRC-IHCP), Ispra
JRC-IHCP (2011) REACH implementation project on nanomaterials (RIP-oN), specific advice on fulfilling information requirements for nanomaterials under REACH, vol 2. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRC-IHCP), Ispra
JRC-IHCP (2011) REACH implementation project on nanomaterials (RIP-oN), specific advice on exposure assessment and hazard/risk characterisation for nanomaterials under REACH, vol 3. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRCIHCP), Ispra
Louekari K (2011) Integrated testing strategies in REACH. EPAA Workshop IST and their impact on the 3Rs, September 2011, Brussels
NANOREG - A common European approach to the regulatory testing of nanomaterials. (2013) European Commission. http://cordis.europa.eu/project/rcn/107159_en.html. Accessed 13 Dec 2015
CORDIS (2015) PROSAFE - promoting the implementation of safe by design. European Commission. http://cordis.europa.eu/project/rcn/194431_en.html. Accessed 26 May 2015
Federal Office of Public Health (FOPH) (2008): Action plan for synthetic nanomaterials. FOPH. http://www.bag.admin.ch/nanotechnologie/12167/?lang=en. Accessed 29 Nov 2014
Federal Office of Public Health (FOPH) (2012) Action plan for synthetic nanomaterials, report of the Federal Council dated 25 April 2012. FOPH. http://www.bag.admin.ch/nanotechnologie/12167/?lang=en. Accessed 29 Nov 2014
Federal Office of Public Health (FOPH), Federal Office for the Environment (FOEN) (2008) Guidelines on the precautionary matrix for synthetic nanomaterials. FOPH, FOEN, Bern
Federal Office of Public Health (FOPH) (2013) Precautionary matrix for synthetic nanomaterials. FOPH. http://www.bag.admin.ch/nanotechnologie/12171/12174/index.html?lang=de. Accessed 29 Nov 2014
EPFL (2013) Directive on the work with engineered nano materials: exposure potential and control measures. vol LEX 1.5.5
Groso A, Petri-Fink A, Magrez A, Riediker M, Meyer T (2010) Management of nanomaterials safety in research environment. Part Fibre Toxicol 7:40
Warheit DB, Borm PJ, Hennes C, Lademann J (2007) Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal Toxicol 19(8):631–643. doi:10.1080/08958370701353080
Stone V, Nowack B, Baun A, van den Brink N, Kammer F, Dusinska M, Handy R, Hankin S, Hassellov M, Joner E, Fernandes TF (2010) Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. Sci Total Environ 408(7):1745–1754. doi:10.1016/j.scitotenv.2009.10.035
Krug H (2011) Quality handbook—standard procedures for nanoparticle testing. http://www.nanopartikel.info/files/methodik/NANOMMUNE-Quality-Handbook-SOPs.pdf
Aitken RJ, Hankin SM, Tran CL, Donaldson K, Stone V, Cumpson P, Johnstone J, Chaudhry Q, Cash S (2007) REFNANO: reference materials for engineered nanoparticle toxicology and metrology. Research Project Final Report defra
DaNa (2009) Methodology of selection, acquisition and evaluation of publications in the Project DaNa. German Ministry of Education and Research. http://www.nanopartikel.info/files/methodik/DaNa_criteria_checklist_2015_form.pdf
NANOVALID - Developing reference methods for nanomaterials (2013) http://cordis.europa.eu/project/rcn/101043_en.html. Accessed 13 Dec 2015
MARINA - managing risks of nanomaterials (2013) http://cordis.europa.eu/project/rcn/93425_en.html. Accessed 13 Dec 2015
Stone V, Pozzi-Mucelli S, Tran L, Aschberger K, Sabella S, Vogel UB, Poland C, Balharry D, Fernandes S, Gottardo S, Hankin S, Hartl M, Hartmann N, Hristozov D, Hund-Rinke K, Johnston H, Marcomini A, Panzer O, Roncato D, Saber AT, Wallin H, Scott-Fordmand JJ (2014) Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy. Part Fibre Toxicol 11:9
NANOREG II (2015) http://cordis.europa.eu/project/rcn/197088_en.html. Accessed 13 Dec 2015
Crist RM, Hall Grossmann J, Patri AK, Stern ST, Dobrovolskaia MA, Adiseshaiah PP, Clogston JD, McNeil SE (2013) Common pitfalls in nanotechnology: lessons learned from NCI’s nanotechnology characterization laboratory. Integr Biol 5:66–73
Joris F, Manshian BB, Peynshaert K, De Smedt SC, Braeckmans K, Soenen SJ (2013) Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. Chem Soc Rev 42(21):8339–8359. doi:10.1039/c3cs60145e
Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM (2007) Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 171(3):99–110. doi:10.1016/j.toxlet.2007.04.008
National Cancer Institute (2014) Nanotechnology characterization laboratory. http://ncl.cancer.gov. Accessed 29 Nov 2014
Knowledge base nanomaterials (2013) http://nanopartikel.info. Accessed 29 Nov 2014
International Organization for Standardization (ISO) (1992) Terms and definitions used in connection with reference materials, ISO Guide 30:1992. ISO, Geneva
Bundesanstalt für Materialforschung und –prüfung (BAM) (2009) Nanoscaled reference materials. BAM (German Federal Institute for Materials Research and Testing). http://www.nanorefmat.bam.de/en/. Accessed Nov 2014
Kroll A, Pillukat MH, Hahn D, Schnekenburger J (2012) Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol 86(7):1123–1136. doi:10.1007/s00204-012-0837-z
Nimesh S (2011) Potential implications of nanoparticle characterization on in vitro and in vivo gene delivery. Ther Deliv 3(11):1347–1356
Donaldson K, Murphy FA, Duffin R, Poland CA (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 7:5
NIA (2015) US and Canada develop classification scheme for nanomaterials. http://www.nanotechia.org/node/18580. Accessed 13 Dec 2015
Hofmann-Amtenbrink M (2010) NanoDiaRA internal deliverable D5.6: guidelines for improving and monitoring research exchange/ethical issues
Hool A, Beuzelin Ollivier M-G, Roubert F (2013) Managing operating procedures in distributed collaborative projects. J Phys Conf Ser 429:012071
Thomas J, Harden A (2008) Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 8(1):45
National Nanotechnology Initiative (NNI) (2015) Glossary. NNI. http://www.nano.gov/aboutnni/glossary. Accessed 18 Dec 2015
Federal Office of Public Health (FOPH) (2011) Glossary. FOPH. http://www.bag.admin.ch/nanotechnologie/glossar/index.html?lang=en. Accessed 18 Dec 2015
Stefaniak AB, Hackley VA, Roebben G, Ehara K, Hankin S, Postek MT, Lynch I, Fu W-E, Linsiniger TPJ, Thünemann AF (2013) Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 7(8):1325–1337
Hirsch C, Roesslein M, Krug HF, Wick P (2011) Nanomaterial cell interactions: are current in vitro tests reliable? Nanomed Nanotechnol Biol Med 6(5):837–847
NANOREG (2014) Factsheets of NANOREG Output. NANOREG—a common European approach to the regulatory testing of nanomaterials. http://nanoreg.eu/index.php/media-and-downloads/factsheets-of-nanoreg-output.html. Accessed 18 Dec 2015
Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Häupl T, Hofmann-Amtenbrink M, Poole AR, Hofmann H, Buttgereit F (2015) Effects of PVA coated nanoparticles on human immune cells. Int J Nanomedicine 10:3429–3445
CCMX (2015) CCMX Winter School 2016. http://www.ccmx.ch/news/news-single/article/269/31/. Accessed 13 Dec 2015
Acknowledgments
The research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 228929, acronym NanoDiaRA. The authors thank Katharina Mader for proofreading.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roubert, F., Beuzelin-Ollivier, MG., Hofmann-Amtenbrink, M. et al. “Nanostandardization” in Action: Implementing Standardization Processes in a Multidisciplinary Nanoparticle-Based Research and Development Project. Nanoethics 10, 41–62 (2016). https://doi.org/10.1007/s11569-015-0248-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11569-015-0248-8